Innovation in transdermal drug delivery technologies drives the market growth. For instance, companies are developing new adhesives and enhancers that are expected to be delivered through transdermal route, which could enhance skin permeability and thus fuel the market growth.
According to the report published by Allied Market Research, Transdermal Drug Delivery Systems Market by Type of Delivery System [Passive (Matrix System and Reservoir System), Active [Structure Based, Electrical Based, (Iontophoresis, Electroporation, and Sonophoresis), and Others] and Application (Analgesics, Hormone Replacement Therapy, Cardiovascular Disorders, Motion Sickness, and Smoking Cessation) – Global Opportunity Analysis and Industry Forecast, 2022-2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Request Free Sample Report Now:
https://www.alliedmarketresearch.com/request-sample/485
Transdermal drug delivery systems are used to deliver drug through intact skin at a controlled rate into the systemic circulation. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as hypertension, diabetes, and angina, are expected to drive the market growth. Moreover, surge in adoption of new delivery system technologies, such as ultrasound, boosts the market growth. However, disadvantages of these delivery systems, such as irritation at the site of application and edema, are expected to impede the market growth.
Key Benefits
- The study provides an in-depth analysis of the global transdermal drug delivery systems market, with current trends and future estimations, to elucidate the imminent investment pockets.
- Quantitative analysis from 2022 to 2030 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
๐๐ฒ๐ ๐ฑ๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐ข๐ฉ๐๐-๐ญ๐ต ๐ถ๐บ๐ฝ๐ฎ๐ฐ๐ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐@ ๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐๐ผ๐ฟ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป: https://www.alliedmarketresearch.com/request-for-customization/485
The key companies operating in the market include Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Acrux Limited, Echo Therapeutics, Inc., and Endo Pharmaceuticals Inc.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.